Skip to content

The Use of Colloid Versus Crystalloid in Post-operative Pediatric Cardiac Patients for Fluid Resuscitation

The Use of Colloid Versus Crystalloid in Post-operative Pediatric Cardiac Patients for Fluid Resuscitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00464126
Enrollment
32
Registered
2007-04-20
Start date
2006-08-31
Completion date
2009-07-31
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Diseases

Keywords

crystalloid, colloid, pediatric, cardiac, resuscitation, Postoperative

Brief summary

The purpose of the study is to help determine if either crystalloid solution or colloid solution is more advantageous as a resuscitative fluid in post-operative pediatric cardiac patients.

Detailed description

The study is designed to help detect if there is an advantage in giving one type of resuscitative fluid versus another in the setting of post-operative pediatric cardiac patients. The two types of fluid being compared are crystalloid solution (normal saline) and colloid solution (5% albumin). The primary outcome measurement will be how much volume of each type of fluid will be required in order to maintain hemodynamic stability as determined by mean arterial blood pressure within predetermined parameters. Other secondary outcomes will include determinations of lactate clearance, inotropic support requirements, urine output, peripheral and pulmonary edema that occurs post-operatively, and the over all costs for each fluid based on number of required boluses and number of hours on mechanical ventilation.

Interventions

5% albumin in 10cc/kg aliquots for postoperative volume resuscitation

saline in 10cc/kg aliquots for postoperative volume resuscitation

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
1 Days to 36 Months
Healthy volunteers
No

Inclusion criteria

* Congenital heart defect with two ventricle anatomy and physiology * Ages: 0 - 36 months of age

Exclusion criteria

* History of bleeding disorder * History of renal disorder

Design outcomes

Primary

MeasureTime frame
maintenance of hemodynamic stability according to an age specific, predetermined, minimal mean arterial blood pressureThroughout the post operative period

Secondary

MeasureTime frame
lactate clearanceThroughout the post operative period
inotropic requirementsthroughout the post operative period
establishment of adequate urine outputThroughout the post operative period
post-operative occurrence of edema (peripheral and pulmonary)Througout the post operative period
monitoring of cost difference as determined by total number of boluses, number of ventilator hours, and length of ICU stayThroughout the ICU stay

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026